Nuclei Online

12/06/2013

http://nucleionline.org/ijar-20000002/

A decade of antiretroviral therapy in Ghana: successes, challenges and way forwardDecember 6, 2013by James A.M. BrandfulIJARNo CommentCorresponding Author :James A.M. BrandfulDepartment of Virology, NMIMR,University of Ghana, GhanaE-mail: [email protected] November 5, 2013; Accept...

11/28/2013

http://nucleionline.org/ijcrd-10000002/

Corresponding Author : Yiyan Liu Nuclear Medicine Service, Department of Radiology, New Jersey Medical School, Rutgers University, USA E-mail: [email protected] Received October 18, 2013; Published November 28, 2013 Copyright: © 2013 Yiyan Liu. This is an open-access article distributed under…

11/28/2013

http://nucleionline.org/ijcrd-10000001/

Corresponding Author : Michele Yip-Schneider Department of Surgery, Indiana University School of Medicine, Indianapolis, IN, USA E-mail: [email protected] Received October 18, 2013; Published November 28, 2013 Copyright: © 2013 Michele Yip-Schneider. This is an open-access article distributed under...

11/03/2013

IJAR editor board update:

Gurudutt N. Pendyala, Ph.D is our pretsigious editor board member,he is an Instructor at Developmental Neuroscience Department, Munroe-Meyer Institute, University of Nebraska Medical Center, USA.

Biography:

After his graduate study in 2005 from the University of Fribourg, Switzerland Dr.Pendyala performed his Post Doctoral studies at The Scripps Research Institute La Jolla, CA and later at the University of Nebraska Medical Center, Omaha where he has successfully used ‘omics’ based genomics, mass spectrometry coupled proteomics and metabolomics approaches to identify disease specific pathogenic markers for neuroAIDS and drugs of abuse using the non-human primate model. In addition to these, he has also studied the pathogenesis of Amyotrophic Lateral Sclerosis (ALS) and was supported by the prestigious Milton Safenowitz Post Doctoral fellowship awarded by The ALS Association. Currently his research focuses on using an integrated systems biology approach to understand synaptic alterations in neurodegenerative and neurodevelopment disorders.

11/03/2013

Efe Sezgin, Ph.D is our prestigious editor board member, he is a research associate at Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, USA.

Biography:

Dr. Efe Sezgin is a faculty member at the department of Epidemiology, Johns Hopkins University Bloomberg School of Public Health. He received his Ph.D. from Stony Brook University focusing on the genetic architecture of interactions among energy driving metabolic pathways. Later, he completed his postdoctoral studies in a Genetic Epidemiology laboratory at the National Cancer Institute (NCI) specializing on designing and conducting studies to discover and map novel genetic variants, identify biological pathways, and elucidate potential genetic and environmental interactions involved in HIV-1 infection, progression to AIDS, therapy response, susceptibility to other opportunistic infections, and cancers among diverse patient cohorts.

Currently he is working on the genetics and epidemiology of cytomegalovirus, hepatitis- B and C co-infections, neurological complications, age related macular degeneration, cataract, and accelerated aging observed among HIV-infected patients.